is compounded tirzepatide as good as zepbound vs. – Forbes Health Zepbound vs Compounded Tirzepatide Side-by-Side

GLP-1RAs medications Mounjaro Ozempic Wegovy weight-loss weight-loss pill newsGP weekly poll Do you believe GPs should play a greater role in shaping the future of Australias health system?

& Ding, W

The American Diabetes Association (ADA) 2024 Standards of Care support GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists, including tirzepatide, particularly in patients with: Established atherosclerotic cardiovascular disease or high cardiovascular risk Chronic kidney disease Need for substantial A1c reduction (tirzepatide typically reduces A1c by 1.5-2.5%) Desire to avoid weight gain or achieve weight loss Inadequate glycemic control on metformin or other oral agents Tirzepatide is not approved for type 1 diabetes or diabetic ketoacidosis

Tirzepatide operates on incretin receptors in the gut and hypothalamus, slowing gastric emptying and suppressing ghrelin